The role of inflammatory factors in the pathogenesis of osteoporosis
Not yet recruiting
- Conditions
- osteoporosisweakening bone disorder1000381610005959
- Registration Number
- NL-OMON29779
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Healthy persons undergoing a bone transplantation from the pelvis for jaw surgery purposes
Exclusion Criteria
Unhealthy persons
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Proliferation and differentiation parameters</p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What inflammatory cytokines are implicated in osteoporosis pathogenesis according to Vrije Universiteit Medisch Centrum's NL-OMON29779 study?
How do anti-inflammatory therapies compare to bisphosphonates in managing osteoporosis-related bone loss in observational studies?
Which inflammatory biomarkers correlate with disease progression in Vrije Universiteit Medisch Centrum's NL-OMON29779 osteoporosis cohort?
What adverse events are observed in osteoporosis patients undergoing anti-inflammatory treatment regimens in observational trials?
How do IL-6 inhibitors and TNF-α blockers synergize with traditional osteoporosis therapies in clinical research?